# A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma

> **NCT04250064** · PHASE2 · RECRUITING · sponsor: **Tata Memorial Centre** · enrollment: 40 (estimated)

## Conditions studied

- DIPG

## Interventions

- **DRUG:** Bevacizumab Injection
- **RADIATION:** Ultra-low-dose RT

## Key facts

- **NCT ID:** NCT04250064
- **Lead sponsor:** Tata Memorial Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-04
- **Primary completion:** 2027-12
- **Final completion:** 2029-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04250064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04250064, "A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04250064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*